These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 11171924)
41. Carnitine for fatigue in multiple sclerosis. Tejani AM; Wasdell M; Spiwak R; Rowell G; Nathwani S Cochrane Database Syst Rev; 2010 Feb; (2):CD007280. PubMed ID: 20166093 [TBL] [Abstract][Full Text] [Related]
42. Modulation of methylation in the FMR1 promoter region after long term treatment with L-carnitine and acetyl-L-carnitine. Pascale E; Battiloro E; Cimino Reale G; Pietrobono R; Pomponi MG; Chiurazzi P; Nicolai R; Calvani M; Neri G; D'Ambrosio E J Med Genet; 2003 Jun; 40(6):e76. PubMed ID: 12807975 [No Abstract] [Full Text] [Related]
43. Cerebral blood flow in patients with chronic cerebrovascular disease: effect of acetyl L-carnitine. Postiglione A; Cicerano U; Soricelli A; De Chiara S; Gallotta G; Salvatore M; Mancini M Int J Clin Pharmacol Res; 1990; 10(1-2):129-32. PubMed ID: 2387659 [TBL] [Abstract][Full Text] [Related]
44. Changes in hepatic lipogenic and oxidative enzymes and glucose homeostasis induced by an acetyl-L-carnitine and nicotinamide treatment in dyslipidaemic insulin-resistant rats. Ferreira MR; Camberos Mdel C; Selenscig D; Martucci LC; Chicco A; Lombardo YB; Cresto JC Clin Exp Pharmacol Physiol; 2013 Mar; 40(3):205-11. PubMed ID: 23278446 [TBL] [Abstract][Full Text] [Related]
45. L-acetylcarnitine in depressed elderly subjects. A cross-over study vs placebo. Tempesta E; Casella L; Pirrongelli C; Janiri L; Calvani M; Ancona L Drugs Exp Clin Res; 1987; 13(7):417-23. PubMed ID: 3308388 [TBL] [Abstract][Full Text] [Related]
46. Primary preventive and secondary interventionary effects of acetyl-L-carnitine on diabetic neuropathy in the bio-breeding Worcester rat. Sima AA; Ristic H; Merry A; Kamijo M; Lattimer SA; Stevens MJ; Greene DA J Clin Invest; 1996 Apr; 97(8):1900-7. PubMed ID: 8621774 [TBL] [Abstract][Full Text] [Related]
47. Effects of acetyl-L-carnitine and oxfenicine on aorta stiffness in diabetic rats. Chang KC; Tseng CD; Lu SC; Liang JT; Wu MS; Tsai MS; Hsu KL Eur J Clin Invest; 2010 Nov; 40(11):1002-10. PubMed ID: 20678118 [TBL] [Abstract][Full Text] [Related]
48. [Effects of L-acetylcarnitine on mental deterioration in the aged: initial results]. Cipolli C; Chiari G Clin Ter; 1990 Mar; 132(6 Suppl):479-510. PubMed ID: 2140973 [TBL] [Abstract][Full Text] [Related]
49. Effect of acetyl-L-carnitine in the treatment of painful peripheral neuropathies in HIV+ patients. Scarpini E; Sacilotto G; Baron P; Cusini M; Scarlato G J Peripher Nerv Syst; 1997; 2(3):250-2. PubMed ID: 10975731 [TBL] [Abstract][Full Text] [Related]
50. Correlation between seminal carnitine and functional spermatozoal characteristics in men with semen dysfunction of various origins. De Rosa M; Boggia B; Amalfi B; Zarrilli S; Vita A; Colao A; Lombardi G Drugs R D; 2005; 6(1):1-9. PubMed ID: 15801863 [TBL] [Abstract][Full Text] [Related]
51. [Acetyl carnitine in the prevention of arrhythmic complications in acute myocardial infarct. Preliminary results]. Giordano MP; Roncarolo PL; Gabasio CA; Corsi M; Trevisani C Minerva Cardioangiol; 1981 May; 29(5):241-6. PubMed ID: 7254540 [No Abstract] [Full Text] [Related]
52. Acetyl-L-carnitine rescues scopolamine-induced memory deficits by restoring insulin-like growth factor II via decreasing p53 oxidation. Wang X; Wang LP; Tang H; Shan WY; Wang X; Liu D; Wu YY; Tian Q; Wang JZ; Zhu LQ Neuropharmacology; 2014 Jan; 76 Pt A():80-7. PubMed ID: 24012657 [TBL] [Abstract][Full Text] [Related]
53. Effects of acetyl-L-carnitine on reaction times in patients with cerebrovascular insufficiency. Arrigo A; Casale R; Buonocore M; Ciano C Int J Clin Pharmacol Res; 1990; 10(1-2):133-7. PubMed ID: 2387660 [TBL] [Abstract][Full Text] [Related]
54. Role of acetyl-L-carnitine in the treatment of cognitive deficit in chronic alcoholism. Tempesta E; Troncon R; Janiri L; Colusso L; Riscica P; Saraceni G; Gesmundo E; Calvani M; Benedetti N; Pola P Int J Clin Pharmacol Res; 1990; 10(1-2):101-7. PubMed ID: 2201652 [TBL] [Abstract][Full Text] [Related]
55. Brain cholinesterases: III. Future perspectives of AD research and clinical practice. Shen ZX Med Hypotheses; 2004; 63(2):298-307. PubMed ID: 15236794 [TBL] [Abstract][Full Text] [Related]
56. Treatment with acetyl-L-carnitine has the potential to improve the clinical course of painful peripheral neuropathies in HIV-positives patients. Famularo G; De Simone C J Peripher Nerv Syst; 1998; 3(3):227-9. PubMed ID: 10959254 [No Abstract] [Full Text] [Related]
57. Acute effects of acetyl-L-carnitine on regional cerebral blood flow in patients with brain ischaemia. Rosadini G; Marenco S; Nobili F; Novellone G; Rodriguez G Int J Clin Pharmacol Res; 1990; 10(1-2):123-8. PubMed ID: 2117587 [TBL] [Abstract][Full Text] [Related]
58. Study of the efficacy and tolerability of L-acetylcarnitine therapy in the senile brain. Bonavita E Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):511-6. PubMed ID: 3781687 [TBL] [Abstract][Full Text] [Related]